An‐Chi Tien

2.1k total citations
40 papers, 1.3k citations indexed

About

An‐Chi Tien is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, An‐Chi Tien has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 13 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in An‐Chi Tien's work include Glioma Diagnosis and Treatment (16 papers), Advanced Breast Cancer Therapies (7 papers) and PARP inhibition in cancer therapy (6 papers). An‐Chi Tien is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Advanced Breast Cancer Therapies (7 papers) and PARP inhibition in cancer therapy (6 papers). An‐Chi Tien collaborates with scholars based in United States, Taiwan and Russia. An‐Chi Tien's co-authors include Hugo J. Bellen, Akhila Rajan, Shi‐Bing Yang, Lily Yeh Jan, Yuh Nung Jan, Hui‐Hsin Tsai, Allison Xu, Roeben N. Munji, Junlei Chang and JJ H. Zhang and has published in prestigious journals such as Science, Neuron and Journal of Clinical Oncology.

In The Last Decade

An‐Chi Tien

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An‐Chi Tien United States 15 751 237 231 223 177 40 1.3k
Giselle Cheung United Kingdom 19 581 0.8× 273 1.2× 283 1.2× 459 2.1× 262 1.5× 32 1.3k
Filippo Casoni Italy 16 656 0.9× 113 0.5× 136 0.6× 230 1.0× 88 0.5× 26 1.4k
Kazuhiko Namikawa Japan 17 736 1.0× 214 0.9× 173 0.7× 534 2.4× 152 0.9× 20 1.4k
Thierry Janet France 20 708 0.9× 208 0.9× 171 0.7× 463 2.1× 149 0.8× 36 1.3k
Marie‐Christine Birling France 25 1.0k 1.4× 201 0.8× 205 0.9× 477 2.1× 64 0.4× 61 1.8k
Wang Zheng China 21 721 1.0× 150 0.6× 216 0.9× 343 1.5× 97 0.5× 43 1.5k
Doğukan Mizrak United States 10 541 0.7× 301 1.3× 79 0.3× 195 0.9× 119 0.7× 18 1.1k
Jacqueline L. Vanderluit Canada 25 1.2k 1.6× 305 1.3× 207 0.9× 366 1.6× 143 0.8× 33 1.8k
Ivy S. Samuels United States 22 1.1k 1.4× 134 0.6× 154 0.7× 451 2.0× 123 0.7× 41 1.6k
Haihong Ye China 19 838 1.1× 208 0.9× 247 1.1× 769 3.4× 85 0.5× 40 1.5k

Countries citing papers authored by An‐Chi Tien

Since Specialization
Citations

This map shows the geographic impact of An‐Chi Tien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An‐Chi Tien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An‐Chi Tien more than expected).

Fields of papers citing papers by An‐Chi Tien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An‐Chi Tien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An‐Chi Tien. The network helps show where An‐Chi Tien may publish in the future.

Co-authorship network of co-authors of An‐Chi Tien

This figure shows the co-authorship network connecting the top 25 collaborators of An‐Chi Tien. A scholar is included among the top collaborators of An‐Chi Tien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An‐Chi Tien. An‐Chi Tien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanai, Nader, Artak Tovmasyan, An‐Chi Tien, et al.. (2025). An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma. Science Translational Medicine. 17(826). eads5813–eads5813.
2.
3.
Sanai, Nader, Yoshie Umemura, Amy Hong, et al.. (2024). A phase 0/1 trigger trial of BDTX-1535 in patients with recurrent high-grade glioma (HGG) with EGFR alterations or fusions.. Journal of Clinical Oncology. 42(16_suppl). 2069–2069. 1 indexed citations
4.
Sanai, Nader, Yoshie Umemura, Jennifer K. Molloy, et al.. (2024). Niraparib efficacy in patients with newly-diagnosed glioblastoma: Clinical readout of a phase 0/2 "trigger" trial.. Journal of Clinical Oncology. 42(16_suppl). 2002–2002. 2 indexed citations
5.
Kennedy, William R., Yun‐Woo Chang, Michael A. Garcia, et al.. (2023). A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 117(2). e115–e115. 4 indexed citations
6.
Sanai, Nader, Jennifer K. Molloy, Amy Hong, et al.. (2023). CTNI-25. A PHASE 0/1B STUDY OF AZD1390 PLUS RADIOTHERAPY IN RECURRENT GLIOBLASTOMA PATIENTS. Neuro-Oncology. 25(Supplement_5). v79–v79.
7.
Mehta, Shwetal, Nader Sanai, Jennifer K. Molloy, et al.. (2023). A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 41(16_suppl). 2069–2069. 3 indexed citations
8.
Johnson, Kevin C., An‐Chi Tien, Jun Jiang, et al.. (2023). CTNI-23. SINGLE CELL TRANSCRIPTOMICS, PHARMACOKINETICS, AND PHARMACODYNAMICS OF COMBINED CDK4/6 AND MTOR INHIBITION IN A PHASE 0 TRIAL OF RECURRENT HIGH-GRADE GLIOMA. Neuro-Oncology. 25(Supplement_5). v78–v79. 2 indexed citations
9.
Sanai, Nader, Jennifer K. Molloy, Amy Hong, et al.. (2023). A phase 0 pharmacokinetic trigger trial of infigratinib in patients with recurrent high-grade glioma.. Journal of Clinical Oncology. 41(16_suppl). 2051–2051. 1 indexed citations
10.
Mehta, Shwetal, Artak Tovmasyan, An‐Chi Tien, et al.. (2021). EXTH-09. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE AURORA KINASE A INHIBITOR LY3295668. Neuro-Oncology. 23(Supplement_6). vi165–vi165. 1 indexed citations
11.
Tien, An‐Chi, Jing Li, Xun Bao, et al.. (2019). A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort. Clinical Cancer Research. 25(19). 5777–5786. 55 indexed citations
12.
Tien, An‐Chi, Jing Li, Xun Bao, et al.. (2019). MNGI-01. A PHASE 0 TRIAL OF RIBOCICLIB IN AGGRESSIVE MENINGIOMA PATIENTS INCORPORATING A TUMOR PHARMACODYNAMIC- AND PHARMACOKINETIC-GUIDED EXPANSION COHORT. Neuro-Oncology. 21(Supplement_6). vi139–vi139. 3 indexed citations
13.
Tsai, Hui‐Hsin, Jianqin Niu, Roeben N. Munji, et al.. (2016). Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science. 351(6271). 379–384. 311 indexed citations
14.
Tong, Chao, Tomoko Ohyama, An‐Chi Tien, et al.. (2011). Rich Regulates Target Specificity of Photoreceptor Cells and N-Cadherin Trafficking in the Drosophila Visual System via Rab6. Neuron. 71(3). 447–459. 31 indexed citations
15.
Yang, Shi‐Bing, Hye Young Lee, David M. Young, et al.. (2011). Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity. Journal of Molecular Medicine. 90(5). 575–585. 85 indexed citations
16.
Rajan, Akhila, An‐Chi Tien, Claire Haueter, Karen L. Schulze, & Hugo J. Bellen. (2009). The Arp2/3 complex and WASp are required for apical trafficking of Delta into microvilli during cell fate specification of sensory organ precursors. Nature Cell Biology. 11(7). 815–824. 78 indexed citations
17.
Tien, An‐Chi, et al.. (2008). Negative-feedback regulation of proneural proteins controls the timing of neural precursor division. Development. 135(18). 3021–3030. 20 indexed citations
18.
Hsu, Shih‐Lan, et al.. (2006). Caspase 3, periodically expressed and activated at G2/M transition, is required for nocodazole-induced mitotic checkpoint. APOPTOSIS. 11(5). 765–771. 30 indexed citations
19.
Tien, An‐Chi, et al.. (2004). POINT: a database for the prediction of protein–protein interactions based on the orthologous interactome. Bioinformatics. 20(17). 3273–3276. 80 indexed citations
20.
Tien, An‐Chi, et al.. (1999). Dynamic expression and cellular localization of the Drosophila 14-3-3ϵ during embryonic development. Mechanisms of Development. 81(1-2). 209–212. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giselle Cheung Breakdown of academic impact, for papers by Filippo Casoni Breakdown of academic impact, for papers by Kazuhiko Namikawa Breakdown of academic impact, for papers by Thierry Janet Breakdown of academic impact, for papers by Marie‐Christine Birling Breakdown of academic impact, for papers by Wang Zheng Breakdown of academic impact, for papers by Doğukan Mizrak Breakdown of academic impact, for papers by Jacqueline L. Vanderluit Breakdown of academic impact, for papers by Ivy S. Samuels Breakdown of academic impact, for papers by Haihong Ye
Rankless by CCL
2026